Molecular Diagnostics
Test Detects Cancer Mutations from Circulating DNA
In cancer patients, apoptotic and necrotic tumor cells release their DNA content into the blood. This is commonly referred to as circulating tumor DNA (ctDNA); and can be used for DNA sequencing or molecular genotyping assays to identify and quantitatively measure those ctDNA molecules bearing somatic mutations. More...30 Aug 2017
![Image: An example of a TaqMan Low Density Array card; each well contains a specific miRNA forward primer, a specific miRNA TaqMan probe, and a reverse \"tail\" primer (Photo courtesy of Dana-Farber Cancer Institute).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2017-08-29/RLJ-296.jpg "Image: An example of a TaqMan Low Density Array card; each well contains a specific miRNA forward primer, a specific miRNA TaqMan probe, and a reverse \\"tail\\" primer (Photo courtesy of Dana-Farber Cancer Institute).")
Gene Expression Profiling Validated for Uveal Melanoma
Uveal melanoma is a cancer of the eye involving the iris, ciliary body, or choroid (collectively referred to as the uvea). Tumors arise from the pigment cells (melanocytes) that reside within the uvea giving color to the eye. More...29 Aug 2017
DNA Sequencing of MRSA Predicts Patient Survival
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that has become resistant to most types of antibiotics, and up to 20% of patients with invasive infections die. Although S. aureus is a common bacterium that lives on the skin, if it gets inside the body through a cut it can cause septicemia. More...23 Aug 2017
New Molecular Test Identifies Colorectal Cancer
Colorectal cancer is one of the leading causes of cancer-related deaths worldwide, with more than 600,000 deaths each year. Among individuals undergoing treatment for the disease, recurrence occurs in 30% to 50% of all cases. The majority of these cases present in the first two to three years following initial diagnosis and treatment. More...23 Aug 2017
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Manual Pipetting Aid
Pipette Controllers macro
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
In Other News
CRISPR Technology Identifies Cancer-Causing Genes
Liquid Biopsy Approach Inspired by Swarm Behavior
Biosensor Device Developed for Zika Diagnosis
Cytokine Concentration Linked to Chronic Fatigue Syndrome
Mutations Related to Hereditary Neuroendocrine Tumors
Blood Test Detects Brain Metastases While Treatable
Neurological Disease Traced to Gene Error
Smartphone-Based ELISA Developed for Blood Antigens
Dried Blood Assessment Equivalent to Drawn Blood Samples
Test Discriminates Between Viral and Bacterial Infections
CRISPR Illuminates Pediatric Bone Marrow Failure Syndrome
Five Vascular Diseases Linked to One Genetic Variant
Liquid Biopsy Could Identify Advanced Breast Cancer Patients
Methods Compared for Chagas Disease Diagnosis
Study Shows Predisposed Cancer Factors in Ashkenazi Jewish Women
Breast Cancer Diagnosed by Measuring Circulating Tumor DNA
Study Highlights Ethnic Diversity of Lupus-Linked Genes
New Genes Found Raise Alzheimer’s Disease Risk
Genetic Variation Associated with Influenza Severity Identified
Newly Driver Mutations Discovered for Medulloblastoma
Antibody-Based ELISA Detects Zika with High Specificity
Novel Non-Invasive Sampling Technique Diagnoses Cutaneous Leishmaniasis
RT-PCR Evaluated for Taenia Detection
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
